Traders should monitor for potential downward pressure on VERA shares, especially if this selling reflects reduced confidence ahead of an upcoming catalyst or clinical readout. Absent a clear explanation, this level of coordinated C-suite selling is typically viewed as a negative signal.
Price Chart
Executive Summary
Five executive officers at Vera Therapeutics, including the CEO and CFO, collectively sold over $1.2 million in shares in a coordinated open-market transaction on February 23, 2026. All sales occurred at the same price, indicating a planned divestment during a short trading window.
Key Financial Metrics
Key Facts
- CEO Fordyce Marshall sold $710,578 worth of shares, the largest individual transaction.
- All five executives sold shares on the same day at $41.9839 per share, totaling $1,184,869.626 in aggregate value.
- Sellers include C-suite leaders across operations, finance, regulatory, and commercial functions, indicating broad insider participation.
- Transactions were open-market sales (Form 4 'S' code), not driven by tax events or option exercises.
- Recent insider activity over the past 30 days shows continued selling pressure, with $1.2M in total dispositions.
Financial Impact
$1.18 million in insider selling over a single day; no offsetting insider purchases reported.
Risk Factors
- Insiders may have access to non-public information suggesting near-term challenges in development or commercialization.
- Perception of insider pessimism could erode retail and institutional investor confidence.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (5 trades, 7d window) | cluster-VERA-1772067605574 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | 8-K | $33.67 $34.00 | ▲ +0.98% | ▲ +0.16% | $30.13 (−10.53%) |
Aug 10, 2026 7w ago | 8-K | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Aug 10, 2026 7w ago | Press Release | $30.29 $32.28 | ▲ +6.57% | ▲ +6.97% | $30.13 (−0.54%) |
Jul 9, 2026 12w ago | 8-K | $42.45 $39.12 | ▼ −7.84% | ▼ −7.71% | $30.13 (−29.03%) |
Jul 7, 2026 12w ago | 8-K | $42.96 $43.13 | ▲ +0.40% | ▼ −0.16% | $30.13 (−29.88%) |
Jun 11, 2026 16w ago | Institutional Cluster | $33.65 $35.01 | ▲ +4.04% | ▲ +3.61% | $30.13 (−10.48%) |
Jun 2, 2026 17w ago | 8-K | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
Jun 2, 2026 17w ago | Press Release | $31.26 $31.81 | ▲ +1.76% | ▲ +4.72% | $30.13 (−3.63%) |
May 7, 2026 21w ago | 8-K | $35.88 $39.15 | ▲ +9.11% | ▲ +7.61% | $30.13 (−16.04%) |
Feb 26, 2026 31w ago | 8-K | $42.35 $38.85 | ▼ −8.26% | ▼ −7.14% | $30.13 (−28.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access